Antiinflammatory Activity of Melatonin in Central Nervous System
Open Access
- 1 September 2010
- journal article
- Published by Bentham Science Publishers Ltd. in Current Neuropharmacology
- Vol. 8 (3), 228-242
- https://doi.org/10.2174/157015910792246155
Abstract
Melatonin is mainly produced in the mammalian pineal gland during the dark phase. Its secretion from the pineal gland has been classically associated with circadian and circanual rhythm regulation. However, melatonin production is not confined exclusively to the pineal gland, but other tissues including retina, Harderian glands, gut, ovary, testes, bone marrow and lens also produce it. Several studies have shown that melatonin reduces chronic and acute inflammation. The immunomodulatory properties of melatonin are well known; it acts on the immune system by regulating cytokine production of immunocompetent cells. Experimental and clinical data showing that melatonin reduces adhesion molecules and pro-inflammatory cytokines and modifies serum inflammatory parameters. As a consequence, melatonin improves the clinical course of illnesses which have an inflammatory etiology. Moreover, experimental evidence supports its actions as a direct and indirect antioxidant, scavenging free radicals, stimulating antioxidant enzymes, enhancing the activities of other antioxidants or protecting other antioxidant enzymes from oxidative damage. Several encouraging clinical studies suggest that melatonin is a neuroprotective molecule in neurodegenerative disorders where brain oxidative damage has been implicated as a common link. In this review, the authors examine the effect of melatonin on several neurological diseases with inflammatory components, including dementia, Alzheimer disease, Parkinson disease, multiple sclerosis, stroke, and brain ischemia/reperfusion but also in traumatic CNS injuries (traumatic brain and spinal cord injury)Keywords
This publication has 105 references indexed in Scilit:
- Randomized, double‐blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatmentJournal of Pineal Research, 2000
- An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's diseaseJournal of Neural Transmission, 2000
- Matrix Metalloproteinases and TIMPs Are Associated With Blood-Brain Barrier Opening After Reperfusion in Rat BrainStroke, 1998
- Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily.Journal of Biological Chemistry, 1997
- Update on the Pathophysiology and Pathology of Acute Spinal Cord InjuryBrain Pathology, 1995
- Melatonin: A peroxyl radical scavenger more effective than vitamin ELife Sciences, 1994
- Calmodulin mediates melatonin cytoskeletal effectsCellular and Molecular Life Sciences, 1993
- Pathophysiology of spinal cord traumaAnnals of Emergency Medicine, 1993
- Degradation of human articular cartilage by neutrophils in synovial fluidArthritis & Rheumatism, 1993
- N-Acetyltransferase activity, hydroxyindole-O-methyltransferase activity, and melatonin levels in the Harderian glands of the female Syrian hamster: Changes during the light: Dark cycle and the effect of 6-parachlorophenylalanine administrationBiochemical and Biophysical Research Communications, 1987